EMLA Cream as Analgesic for Outpatient Gynecological Procedures

• Status: Enrolling by invitation
• Trial end date: 2024-02-28
• Target enrollment: 0
• Participant gender: Female

Summary

The goal of this clinical trial is to compare pain perception in the study participant population undergoing the following gynecological procedures: Intra Uterine Device (IUD) insertion, hysteroscopy, and endometrial biopsy and given either Eutectic Mixture of Local Anesthetics (EMLA) cream or a placebo. The main question to answer is:

• Does EMLA cream reduce pain when administered during the following gynecological procedures: IUD insertion, hysteroscopy, and endometrial biopsy?

Participants will be asked to do assess their pain on the Visual Analogue Scale through 3 times during the procedure. Researchers will compare the study group with those receiving placebo group to see if there is a difference in pain scores.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: CAMC Health System
• Treatments: Lidocaine, Prilocaine Drug Combination

Criteria

Inclusion Criteria:

• Patient will undergo one of the following procedures: intra-uterine device insertion, hysteroscopy, or endometrial biopsies

Exclusion Criteria:

• Known hypersensitivity to amide anesthetics

• Pre-existing methemoglobinemia